Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Shareholders Equity (Quarterly) : 13.95M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 13.95M |
| December 31, 2025 | 15.78M |
| September 30, 2025 | 19.11M |
| June 30, 2025 | 20.52M |
| March 31, 2025 | 16.88M |
| December 31, 2024 | 16.33M |
| September 30, 2024 | 18.44M |
| June 30, 2024 | 11.79M |
| March 31, 2024 | 12.76M |
| December 31, 2023 | 13.88M |
| September 30, 2023 | 15.46M |
| June 30, 2023 | 10.55M |
| March 31, 2023 | 11.99M |
| December 31, 2022 | 13.42M |
| September 30, 2022 | 15.75M |
| June 30, 2022 | 20.71M |
| March 31, 2022 | 24.37M |
| December 31, 2021 | 30.50M |
| September 30, 2021 | 37.68M |
| June 30, 2021 | 45.00M |
| March 31, 2021 | 52.96M |
| December 31, 2020 | 44.15M |
| September 30, 2020 | 53.66M |
| June 30, 2020 | 59.88M |
| March 31, 2020 | 64.10M |
| Date | Value |
|---|---|
| December 31, 2019 | 69.85M |
| September 30, 2019 | 77.42M |
| June 30, 2019 | 81.39M |
| March 31, 2019 | 84.93M |
| December 31, 2018 | 87.89M |
| September 30, 2018 | 90.75M |
| June 30, 2018 | 91.04M |
| March 31, 2018 | 13.60M |
| December 31, 2017 | 15.80M |
| September 30, 2017 | 6.532M |
| June 30, 2017 | 6.242M |
| March 31, 2017 | 8.298M |
| December 31, 2016 | 11.08M |
| September 30, 2016 | 15.53M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 17.88M |
| December 31, 2015 | 21.54M |
| September 30, 2015 | 25.06M |
| June 30, 2015 | 27.42M |
| March 31, 2015 | 29.49M |
| December 31, 2014 | 31.41M |
| September 30, 2014 | 33.25M |
| June 30, 2014 | 36.35M |
| March 31, 2014 | 37.95M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.67M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Revium Recovery, Inc. | 18.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.03M |
| Total Liabilities (Quarterly) | 2.079M |
| Current Ratio | 7.709 |